Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LQDA | LIQUIDIA CORP | $71.63 | $17.59 | 307.19% | 298.44x | 20.97x | 21.88x | 58.66x | 1.47x | $41.15M | 0.65% | $108.58M | 1.23 | $6.33B | 118.13 | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $6.93 | $2.91 | 137.88% | 99.00x | 64.71x | 3.75x | 91.95x | 0.91x | $47.52M | 4.03% | $13.01M | 0.08 | $1.34B | 25.14 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $289.39 | $93.15 | 210.66% | 66.37x | 38.37x | 8.97x | 35.93x | 1.38x | $641.34M | 1.67% | $1.08B | 8.09 | $39.90B | 43.16 | ||
| CORT | CORCEPT THERAPEUTICS INC | $83.25 | $20.67 | 302.81% | 180.98x | 159.00x | 11.30x | 14.01x | 1.53x | $119.79M | 1.38% | $637.99M | 6.11 | $8.84B | -1,287.20 | ||
| KRYS | KRYSTAL BIOTECH INC | $321.55 | $95.01 | 238.42% | 41.49x | 40.44x | 22.57x | 7.42x | 1.98x | $237.38M | 2.52% | $1.28B | 43.59 | $8.99B | 42.00 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $51.58 | $17.25 | 198.95% | 52.63x | 40.40x | 5.23x | 6.55x | 1.43x | $164.23M | 4.16% | $605.69M | 7.92 | $3.79B | 33.97 | ||
| HALO | HALOZYME THERAPEUTICS INC | $70.73 | $71.06 | -0.47% | 23.90x | 8.53x | 5.54x | 38.20x | 0.43x | $667.65M | 7.99% | $219.64M | 1.86 | $10.22B | 16.39 | ||
| RPRX | ROYALTY PHARMA PLC | $55.29 | $39.73 | 39.17% | 28.95x | 10.37x | 9.90x | 3.20x | 0.62x | $2.34B | 9.69% | $9.94B | 22.75 | $40.21B | 34.56 | ||
| ASND | ASCENDIS PHARMA A | $215.60 | $80.38 | 168.23% | 22.85x | 14.45x | 13.15x | 23.33x | 2.34x | $52.94M | 0.40% | $574.09M | 9.24 | $13.77B | 147.68 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $12.97 | $15.90 | -18.45% | 6.33x | 27.05x | 6.19x | 3.73x | 0.84x | $56.42M | 7.45% | $205.80M | 3.52 | $672.27M | 4.65 | ||
| ADMA | ADMA BIOLOGICS INC | $8.32 | $9.65 | -13.79% | 12.06x | 9.10x | 3.85x | 4.94x | 0.46x | $107.90M | 5.49% | $390.33M | 1.65 | $1.99B | 8.97 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $55.54 | $41.62 | 33.45% | 39.67x | 14.65x | 3.30x | 1.73x | 0.54x | $767.06M | 7.18% | $6.21B | 32.27 | $9.09B | 18.85 | ||
| VCEL | VERICEL CORP | $38.57 | $9.10 | 323.81% | 89.70x | 80.00x | 6.70x | 5.53x | 1.89x | $47.49M | 2.42% | $356.23M | 7.02 | $1.95B | 48.37 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $236.17 | $49.21 | 379.93% | 502.49x | 9.18x | 3.29x | 3.27x | 1.69x | $1.30B | 8.88% | $4.53B | 73.22 | $18.38B | 27.22 | ||
| TGTX | TG THERAPEUTICS INC | $48.05 | $16.97 | 183.18% | 14.92x | 34.35x | 9.91x | 12.61x | 236.46x | -$14.19M | -0.20% | $583.13M | 4.04 | $7.66B | 51.09 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $35.20 | $35.61 | -1.14% | 13.91x | 9.57x | 2.26x | 2.24x | 0.53x | $341.79M | 16.79% | $910.35M | 15.75 | $1.61B | 6.78 | ||
| TECH | BIO-TECHNE CORP | $54.02 | $15.26 | 254.01% | 76.08x | 27.53x | 6.97x | 4.06x | 1.57x | $269.60M | 3.19% | $2.09B | 13.34 | $8.54B | 33.36 | ||
| SPRO | SPERO THERAPEUTICS INC | $2.70 | $5.71 | -52.74% | 10.00x | 3.95x | 2.53x | 2.95x | 0.21x | $7.24M | 4.67% | $52.93M | 0.92 | $102.68M | 6.63 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $254.57 | $94.02 | 170.77% | 32.22x | 28.05x | 18.44x | 5.12x | 1.62x | $122.22M | 2.41% | $997.32M | 50.16 | $5.44B | 24.11 | ||
| UTHR | UNITED THERAPEUTICS CORP | $545.40 | $242.28 | 125.11% | 18.63x | 19.17x | 7.48x | 3.92x | 2.06x | $1.02B | 4.29% | $5.90B | 135.66 | $21.87B | 12.76 | ||
| EXEL | EXELIXIS INC | $53.50 | $30.72 | 74.13% | 17.15x | 16.24x | 5.82x | 6.95x | 1.25x | $917.69M | 6.64% | $1.94B | 7.49 | $13.39B | 12.68 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.43 | $2.45 | 40.01% | 14.29x | 14.50x | 2.10x | 3.32x | 0.96x | $4.11M | 1.49% | $82.33M | 1.03 | $209.21M | 9.85 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $445.04 | $167.27 | 166.06% | 26.16x | 22.77x | 9.26x | 5.83x | 1.91x | $3.71B | 3.28% | $19.36B | 76.20 | $109.45B | 20.29 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $31.37 | $12.20 | 157.15% | 17.33x | 16.00x | 6.42x | 3.79x | 3.89x | $208.13M | 5.43% | $1.01B | 8.28 | $3.09B | 9.21 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $611.48 | $434.28 | 40.80% | 14.37x | 13.00x | 4.26x | 2.04x | 0.97x | $4.11B | 6.47% | $31.42B | 302.15 | $63.85B | 11.11 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $2.05 | $1.26 | 63.32% | 10.79x | 9.44x | 2.14x | 2.46x | 2.66x | $13.00M | 7.95% | $67.23M | 0.84 | $131.94M | 5.91 | ||
| INCY | INCYTE CORP | $107.83 | $66.60 | 61.91% | 14.79x | 13.76x | 4.01x | 3.83x | 1.27x | $1.45B | 6.75% | $5.62B | 28.21 | $18.11B | 9.68 | ||
| VCYT | VERACYTE INC | $47.42 | $7.57 | 526.39% | 42.72x | 42.52x | 6.96x | 2.81x | 9.10x | $155.34M | 4.12% | $1.34B | 16.90 | $3.56B | 30.93 | ||
| SRPT | SAREPTA THERAPEUTICS INC | $15.00 | $3.59 | 317.49% | 25.00x | 4.09x | 0.72x | 1.05x | 11.31x | $109.24M | 6.93% | $1.51B | 14.34 | $2.16B | 26.06 | ||
| MDXG | MIMEDX GROUP INC | $3.69 | $1.25 | 195.20% | 17.57x | -43.82x | 1.41x | 2.26x | 8.36x | $69.36M | 12.66% | $242.94M | 1.64 | $407.43M | 7.48 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.